Five Years of Ublituximab in Multiple Sclerosis

Authors

Hari P. Miskin
Wynn Dr
Derrick Robertson (ORCID: https://orcid.org/0000-0001-8993-0981)
Enrique Álvarez (ORCID: https://orcid.org/0000-0001-5854-9643)
Peter Sportelli
HP Hartung
Koby Mok
Peiqing Qian (ORCID: https://orcid.org/0000-0003-4774-7788)
Edward J. Fox
Karthik Bodhinathan
Sibyl Wray
Lawrence Steinman
Chris Rowland
Bruce A. C. Cree

Institutions

The University of Sydney (AU)
University of California, San Francisco (US)
University of South Florida (US)
UNSW Sydney (AU)
Swedish Medical Center (US)
Consultants in Neurology (US)
Tenax Therapeutics (United States) (US)
Heinrich Heine University Düsseldorf (DE)
University of Warmia and Mazury in Olsztyn (PL)
University of Colorado Anschutz Medical Campus (US)
Palacký University Olomouc (CZ)
University of Tennessee at Knoxville (US)
Stanford University (US)

Publication Details

Journal: JAMA Neurology
Published: 2026-02-16
DOI: https://doi.org/10.1001/jamaneurol.2026.0007
Primary Topic: Multiple Sclerosis Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Five Years of Ublituximab in Multiple Sclerosis

Hari P. Miskin, Wynn Dr, Derrick Robertson, Enrique Álvarez et al.

Feb 16, 2026

JAMA Neurology

Multiple Sclerosis Research Studies

article

Five Years of Ublituximab in Multiple Sclerosis

Hari P. Miskin, Wynn Dr, Derrick Robertson, Enrique Álvarez, Peter Sportelli, HP Hartung, Koby Mok, Peiqing Qian, Edward J. Fox, Karthik Bodhinathan, Sibyl Wray, Lawrence Steinman, Chris Rowland, Bruce A. C. Cree

February 16, 2026article en

Abstract

No abstract available for this paper.

JAMA Neurology

The University of Sydney (AU), University of California, San Francisco (US), University of South Florida (US), UNSW Sydney (AU), Swedish Medical Center (US), Consultants in Neurology (US), Tenax Therapeutics (United States) (US), Heinrich Heine University Düsseldorf (DE), University of Warmia and Mazury in Olsztyn (PL), University of Colorado Anschutz Medical Campus (US), Palacký University Olomouc (CZ), University of Tennessee at Knoxville (US), Stanford University (US)

Openalex Percentile: Top 56%

Multiple Sclerosis Research Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Five Years of Ublituximab in Multiple Sclerosis — Hari P. Miskin, Wynn Dr, et al. · JAMA Neurology (2026) | TGRS Research Map | TGRS